ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
ImmuCell Corporation announced preliminary, unaudited sales results for Q1 2026 showing a 28.4% increase in total product sales to $10.4 million compared to Q1 2025. Domestic sales rose significantly by 35.7%, driven primarily by Tri-Shield® First Defense® sales which grew 38.5%. International sales declined by 30.2%. The company attributes strong …